First aid therapy for corrosive chemical eye burns: results of a 30-year longitudinal study with two different decontamination concepts.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 26 01 2019
accepted: 02 05 2019
revised: 01 04 2019
pubmed: 31 5 2019
medline: 7 8 2019
entrez: 1 6 2019
Statut: ppublish

Résumé

There is currently uncertainty about the most efficacious decontamination solution for corrosive chemical eye burns. This 30-year longitudinal study evaluated the relative efficacy of two different decontamination methods. Passive decontamination consists of rinsing with tap water, 0.9% normal saline, isotonic buffered phosphate solution, or Ringer's lactate. Active decontamination adds an amphoteric, polyvalent, and chelating component with Previn® (Diphoterine®) solution (Laboratoire Prevor, Valmondois, France). A prospective evaluation of patients treated in two specialized eye clinics for eye burns was begun in 1988. Recorded data included exposure circumstances, type of corrosive, different types of first therapy, and clinical treatment and outcome. Patients were treated from clinic admission and up to 24 h after the corrosive chemical burn with rinsing for 15 min using two different protocols. From 1988 to 2005, sterile 0.9% normal saline or Ringer's lactate was used. Since 2006, sterile, hypertonic, amphoteric Previn® solution was used. Comparative statistical analysis was done with the Fisher contingency tables and Wilcoxon tests. There were a total of 1495 patients with 2194 chemically burned eyes. In 1988-2005, the annual incidence was 66.1/year; in 2006-2017, it was 65.5/year. Similar incidences were noted when initial rinsing was with tap water or isotonic buffered phosphate solutions. There was a significantly more severe outcome of corrosive chemical eye burns with any first aid rinsing solutions other than Previn® solution or tap water was used (p < 0.001). Previn® solution or tap water rinsing in the pre-hospital setting and secondary rinsing with Previn® solution in the hospital decreased lesion severity in comparison with all other rinsing solutions (p < 0.001). The frequency of corrosive chemical eye burns was comparatively high despite tightening of occupational health and safety regulations over the past 30 years. The severity of corrosive chemical eye burns has been dramatically decreased since the introduction of Previn® solution for initial and secondary rinsing. A new protocol for immediate Previn® solution use by the Cologne Fire Brigade and secondary Previn® solution rinsing in hospital has reduced the frequency of severe corrosive chemical eye burns to less than 60% as compared to the period of 1988-2005 when other rinsing solutions were utilized.

Identifiants

pubmed: 31147840
doi: 10.1007/s00417-019-04350-x
pii: 10.1007/s00417-019-04350-x
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Pagination

1795-1803

Références

Burns. 2001 Aug;27(5):459-64
pubmed: 11451598
Burns. 2005 Mar;31(2):205-11
pubmed: 15683694
Graefes Arch Clin Exp Ophthalmol. 2005 Aug;243(8):780-4
pubmed: 15756579
Acta Ophthalmol Scand. 2005 Aug;83(4):467-70
pubmed: 16029272
Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):845-54
pubmed: 16365735
Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1507-13
pubmed: 17492301
Burns. 2008 Nov;34(7):1027-32
pubmed: 18485603
Am J Emerg Med. 1991 May;9(3):228-31
pubmed: 1850282
Br J Ophthalmol. 2010 Nov;94(11):1519-22
pubmed: 20650912
Curr Eye Res. 2012 Sep;37(9):787-93
pubmed: 22667345
JAMA Ophthalmol. 2015 Mar;133(3):245
pubmed: 25474079
JAMA Ophthalmol. 2016 Oct 1;134(10):1119-1124
pubmed: 27490908
Klin Monbl Augenheilkd. 1994 Aug;205(2):86-92
pubmed: 7967411
Klin Monbl Augenheilkd. 1993 Dec;203(6):397-402
pubmed: 8145483
Klin Monbl Augenheilkd. 1993 Jul;203(1):34-42
pubmed: 8411890

Auteurs

N Wiesner (N)

Department of Ophthalmology Cologne Merheim, Kliniken der Stadt Köln, Ostmerheimer Str. 200, 51109, Cologne, Germany.

R M Dutescu (RM)

Department of Ophthalmology Cologne Merheim, Kliniken der Stadt Köln, Ostmerheimer Str. 200, 51109, Cologne, Germany.

D Uthoff (D)

Department of Ophthalmology Cologne Merheim, Kliniken der Stadt Köln, Ostmerheimer Str. 200, 51109, Cologne, Germany.

A Kottek (A)

, Aachen, Germany.

M Reim (M)

Department of Ophthalmology, RWTH Aachen University, Pauwelsstr. 30, D-52057, Aachen, Germany.

N Schrage (N)

Department of Ophthalmology Cologne Merheim, Kliniken der Stadt Köln, Ostmerheimer Str. 200, 51109, Cologne, Germany. schragen@kliniken-Koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH